Annual report pursuant to Section 13 and 15(d)

Equity Method Investments - Summary of Financial Information (Details)

v3.24.1.u1
Equity Method Investments - Summary of Financial Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Feb. 29, 2024
Feb. 28, 2023
Feb. 29, 2024
Feb. 28, 2023
Feb. 28, 2022
Schedule of Equity Method Investments [Line Items]          
Current assets $ 3,729.5 $ 3,496.1 $ 3,729.5 $ 3,496.1  
Current liabilities 3,141.7 2,968.3 3,141.7 2,968.3  
Noncontrolling interests 321.5 320.3 321.5 320.3  
Net sales 2,139.2 1,997.8 9,961.8 9,452.6 $ 8,820.7
Gross profit (loss) 1,039.2 961.2 5,017.5 4,769.0 4,707.3
Net income (loss)     1,765.2 (38.5) 1.0
Net income (loss) attributable to CBI 392.4 223.0 1,727.4 (71.0) (40.4)
Canopy equity method investment          
Schedule of Equity Method Investments [Line Items]          
Current assets 300.0 865.4 300.0 865.4  
Noncurrent assets 726.8 1,362.9 726.8 1,362.9  
Current liabilities 167.1 500.8 167.1 500.8  
Noncurrent liabilities 448.3 665.2 448.3 665.2  
Noncontrolling interests $ 0.1 $ 2.1 0.1 2.1  
Net sales     254.9 339.3 444.3
Gross profit (loss)     (22.4) (125.7) (18.6)
Net income (loss)     (915.7) (2,466.0) (274.3)
Net income (loss) attributable to CBI     $ (897.5) $ (2,447.9) $ 328.7